Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response

Clinical trial NCT07670715 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07670715
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Non-small Cell Lung Cancer (NSCLC)Thoracic Radiotherapy Immune Checkpoint Inhibitors Neoadjuvant Chemoimmunotherapy

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.